A low score and new breathlessness
A person with longstanding inflammatory arthritis attends review after improvement in joint swelling. The composite joint activity score is now low, and the person is pleased with the hand function gained. During the conversation, the person describes new progressive breathlessness and a dry cough that limit walking to the shops. A colleague proposes continuing the same plan without further assessment because the joint score has improved. The physician recognizes that pulmonary disease, infection, medicine effects and unrelated cardiopulmonary conditions can produce overlapping symptoms. The joint score does not measure all organ involvement or treatment risks. The review must therefore address the new symptoms promptly while preserving the useful functional information and involving the appropriate clinical services.
1. What does the low joint score establish?
Read the worked answer
It summarizes specified aspects of joint disease activity within its framework. It does not exclude lung disease, infection, treatment toxicity or another cause of new breathlessness.
2. How should the plan change?
Read the worked answer
Assess the new cardiopulmonary concern promptly through the qualified pathway and relevant differential. Review treatment and functional goals in context rather than changing medicines automatically from the written scenario.